Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wedbush Maintains Neutral on Twitter, Lowers Price Target to $52

Wedbush analyst Ygal Arounian maintains Twitter (NYSE:TWTR) with a Neutral and lowers the price target from $69 to $52.

byBenzinga Newsdesk

November 30, 2021

1 minute read

Wedbush analyst Ygal Arounian maintains Twitter (NYSE:TWTR) with a Neutral and lowers the price target from $69 to $52.

Coupang’s EBITDA Trajectory Triggers Price Target Boost By This Analyst

By Anusuya Lahiri

Today, 5:23 AM

Mizuho analyst James Lee maintained Coupang Inc (NYSE:CPNG) with a Neutral and raised the price target from $18 to $22. Coupang clocked 12.5% revenue growth…

CPNG

Analyst Ratings

Where Dun & Bradstreet Hldgs Stands With Analysts

By Benzinga Insights

Today, 5:23 AM

Dun & Bradstreet Hldgs (NYSE:DNB) has observed the following analyst ratings within the last quarter:

DNB

RBC Capital Cuts EverGen Infrastructure Price Target By 16%

By Akanksha Bakshi

Today, 5:23 AM

EverGen Infrastructure Corp (TSXV: EVGN) price target has been lowered to C$5 from C$6 by RBC Capital analyst Nelson Ng. The analyst maintained the Outperform rating on the shares. The analyst states that EverGen has a number of near-term opportunities across Canada to grow its RNG production capacity significantly.

EVGIF

Analyst Ratings

The Latest Analyst Ratings for Iovance Biotherapeutics

By Benzinga Insights

Today, 5:23 AM

Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

IOVA

Wedbush Maintains Neutral on Twitter, Lowers Price Target to $52

Related Posts

Coupang’s EBITDA Trajectory Triggers Price Target Boost By This Analyst

Where Dun & Bradstreet Hldgs Stands With Analysts

RBC Capital Cuts EverGen Infrastructure Price Target By 16%

The Latest Analyst Ratings for Iovance Biotherapeutics